[Analysis of Excess Mortality in Switzerland in 2020 before the 2

Analyse de la surmortalité en Suisse en 2020 avant la 2

Journal

Revue medicale suisse
ISSN: 1660-9379
Titre abrégé: Rev Med Suisse
Pays: Switzerland
ID NLM: 101219148

Informations de publication

Date de publication:
17 Mar 2021
Historique:
entrez: 23 3 2021
pubmed: 24 3 2021
medline: 26 3 2021
Statut: ppublish

Résumé

An analysis of excess mortality in Switzerland in 2020 before the 2nd wave of COVID-19 is proposed by comparing the number of deaths observed in 2020 with those of the last five years, while taking into account population growth. Three periods are identified : before, during and after the 1st wave of COVID-19. Over all these periods, a sub-mortality of -3.3 % is obtained at the national level. However, if we restrict the analysis to the period during the first wave and to the cantons most affected by the virus, we obtain an important excess mortality, up to more than 80 % in Ticino, showing that these calculations depend crucially on when, where and for whom the deaths are counted. Such an analysis will have to be repeated once the 2nd wave is over in order to estimate the overall impact of the epidemic on excess mortality in Switzerland. Une analyse de la surmortalité en Suisse en 2020 avant la 2

Autres résumés

Type: Publisher (fre)
Une analyse de la surmortalité en Suisse en 2020 avant la 2

Identifiants

pubmed: 33755359
pii: RMS0730-003

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

518-520

Déclaration de conflit d'intérêts

Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.

Auteurs

Valentin Rousson (V)

Unisanté, 1011 Lausanne.

Aziz Chaouch (A)

Unisanté, 1011 Lausanne.

Murielle Bochud (M)

Unisanté, 1011 Lausanne.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH